| Dr Keith Stacy Patterson, DO | |
|
10512 North 110th East Avenue, Owasso, OK 74055-6636 | |
| (918) 376-8900 | |
| (918) 272-7475 |
| Full Name | Dr Keith Stacy Patterson |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 20 Years |
| Location | 10512 North 110th East Avenue, Owasso, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306853874 | NPI | - | NPPES |
| 200091850A | Medicaid | OK | |
| 4322 | Other | OK | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 4322 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Elara Caring Xxv | Mcalester, OK | Home health agency |
| Bailey Medical Center, Llc | Owasso, OK | Hospital |
| Hillcrest Medical Center | Tulsa, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Legacy Healthcare Services Inc | 2163339722 | 2654 |
| Ahs Oklahoma Physician Group Llc | 9436122496 | 298 |
News Archive
Mederi Therapeutics Inc announced today that it has received a CE Mark authorizing the European distribution and use of Mederi's second generation of the Stretta and Secca Systems. The Stretta System is for treatment of gastric reflux disease, commonly known as GERD, and the Secca System is for treatment of bowel control disorder, or BCD. These latest systems include a streamlined user interface, significant improvements in ease of use, and are smaller, lighter, and highly portable.
In the Sept. 9, 2010 issue of Neuron, Neurogenetic Pharmaceuticals, Inc. (NGP) reports proof of concept studies that show its proprietary compound, NGP 555, is effective in preventing the amyloid pathology of Alzheimer's disease (AD) in a transgenic mouse model.
A plane has to be going pretty fast for a mere raindrop to crack its windshield, but it can happen. Now, new models of the physics behind the improbable feat may just help doctors crack kidney stones to pieces.
AIDS Healthcare Foundation (AHF) today filed a lawsuit against the Food and Drug Administration (FDA) over its denial of AHF's Freedom of Information Act (FOIA) requests regarding correspondence between the FDA and Gilead Sciences regarding its potential application to the FDA to expand the use of its AIDS drug, Truvada, for use as an HIV prevention pill for pre-exposure prophylaxis (PrEP) in uninfected individuals.
Antimicrobial medications intended to prevent surgical site infections are appropriately administered to patients (within one hour before incision) only 55.7 percent of the time, according to a study published in the February issue of Archives of Surgery.
› Verified 4 days ago
| Entity Name | Ahs Oklahoma Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235182775 PECOS PAC ID: 9436122496 Enrollment ID: O20040817001197 |
News Archive
Mederi Therapeutics Inc announced today that it has received a CE Mark authorizing the European distribution and use of Mederi's second generation of the Stretta and Secca Systems. The Stretta System is for treatment of gastric reflux disease, commonly known as GERD, and the Secca System is for treatment of bowel control disorder, or BCD. These latest systems include a streamlined user interface, significant improvements in ease of use, and are smaller, lighter, and highly portable.
In the Sept. 9, 2010 issue of Neuron, Neurogenetic Pharmaceuticals, Inc. (NGP) reports proof of concept studies that show its proprietary compound, NGP 555, is effective in preventing the amyloid pathology of Alzheimer's disease (AD) in a transgenic mouse model.
A plane has to be going pretty fast for a mere raindrop to crack its windshield, but it can happen. Now, new models of the physics behind the improbable feat may just help doctors crack kidney stones to pieces.
AIDS Healthcare Foundation (AHF) today filed a lawsuit against the Food and Drug Administration (FDA) over its denial of AHF's Freedom of Information Act (FOIA) requests regarding correspondence between the FDA and Gilead Sciences regarding its potential application to the FDA to expand the use of its AIDS drug, Truvada, for use as an HIV prevention pill for pre-exposure prophylaxis (PrEP) in uninfected individuals.
Antimicrobial medications intended to prevent surgical site infections are appropriately administered to patients (within one hour before incision) only 55.7 percent of the time, according to a study published in the February issue of Archives of Surgery.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Keith Stacy Patterson, DO 10512 N 110th East Ave, Owasso, OK 74055-6636 Ph: (918) 376-8900 | Dr Keith Stacy Patterson, DO 10512 North 110th East Avenue, Owasso, OK 74055-6636 Ph: (918) 376-8900 |
News Archive
Mederi Therapeutics Inc announced today that it has received a CE Mark authorizing the European distribution and use of Mederi's second generation of the Stretta and Secca Systems. The Stretta System is for treatment of gastric reflux disease, commonly known as GERD, and the Secca System is for treatment of bowel control disorder, or BCD. These latest systems include a streamlined user interface, significant improvements in ease of use, and are smaller, lighter, and highly portable.
In the Sept. 9, 2010 issue of Neuron, Neurogenetic Pharmaceuticals, Inc. (NGP) reports proof of concept studies that show its proprietary compound, NGP 555, is effective in preventing the amyloid pathology of Alzheimer's disease (AD) in a transgenic mouse model.
A plane has to be going pretty fast for a mere raindrop to crack its windshield, but it can happen. Now, new models of the physics behind the improbable feat may just help doctors crack kidney stones to pieces.
AIDS Healthcare Foundation (AHF) today filed a lawsuit against the Food and Drug Administration (FDA) over its denial of AHF's Freedom of Information Act (FOIA) requests regarding correspondence between the FDA and Gilead Sciences regarding its potential application to the FDA to expand the use of its AIDS drug, Truvada, for use as an HIV prevention pill for pre-exposure prophylaxis (PrEP) in uninfected individuals.
Antimicrobial medications intended to prevent surgical site infections are appropriately administered to patients (within one hour before incision) only 55.7 percent of the time, according to a study published in the February issue of Archives of Surgery.
› Verified 4 days ago
Bryan Vannuel Marsh, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 13616 E 103rd Street N, Suite A, Owasso, OK 74055 Phone: 918-274-8555 Fax: 918-274-8556 | |
Dr. David Lee Smith, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 13600 E 86th St N, Ste 100, Owasso, OK 74055 Phone: 918-272-9313 Fax: 918-403-6311 | |
Sharon Sodano Barnes, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13600 E 86th St N, Owasso, OK 74055 Phone: 918-272-2247 | |
Dr. Jack Robin Snedden Iii, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 10502 North 110th East Avenue, Owasso, OK 74055 Phone: 918-376-8590 Fax: 918-376-8549 | |
Chelsea Leigh Mcdonald, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 8551 N 125th East Ave Ste 175, Owasso, OK 74055 Phone: 918-265-3797 | |
Caleb Nunley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12455 E 100th St N, Ste. 120, Owasso, OK 74055 Phone: 918-272-9464 Fax: 918-272-9512 |